Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation.

Ahmed K Al Atya, Yanath Belguesmia, Gabrielle Chataigne, Rozenn Ravallec, Anne Vachée, Sabine Szunerits, Rabah Boukherroub, Djamel Drider
Author Information
  1. Ahmed K Al Atya: Université de Lille 1 Sciences et Technologies - Institut Charles Viollette Lille, France.
  2. Yanath Belguesmia: Université de Lille 1 Sciences et Technologies - Institut Charles Viollette Lille, France.
  3. Gabrielle Chataigne: Université de Lille 1 Sciences et Technologies - Institut Charles Viollette Lille, France.
  4. Rozenn Ravallec: Université de Lille 1 Sciences et Technologies - Institut Charles Viollette Lille, France.
  5. Anne Vachée: Hôpital Victor Provo de Roubaix Roubaix, France.
  6. Sabine Szunerits: Institut d'Electronique, de Microélectronique et de Nanotechnologie, UMR CNRS 8520, Université Lille 1 Lille, France.
  7. Rabah Boukherroub: Institut d'Electronique, de Microélectronique et de Nanotechnologie, UMR CNRS 8520, Université Lille 1 Lille, France.
  8. Djamel Drider: Université de Lille 1 Sciences et Technologies - Institut Charles Viollette Lille, France.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has become a worrisome superbug. This work aimed at studying the effects of two class IIb bacteriocins, enterocins DD28 and DD93 as anti-MRSA agents. Thus, these bacteriocins were purified, from the cultures supernatants of Enterococcus faecalis 28 and 93, using a simplified purification procedure consisting in a cation exchange chromatography and a reversed-phase high-performance liquid chromatography. The anti-Staphylococcal activity was shown in vitro by the assessment of the minimal inhibitory concentration (MIC), followed by a checkerboard and time-kill kinetics experiments. The data unveiled a clear synergistic effect of enterocins DD28 and DD93 in combination with erythromycin or kanamycin against the clinical MRSA-S1 strain. Besides, these combinations impeded as well the MRSA-S1 clinical strain to setup biofilms on stainless steel and glace devices.

Keywords

References

  1. Int J Food Microbiol. 2014 Nov 17;191:116-24 [PMID: 25261829]
  2. J Infect Chemother. 2015 May;21(5):330-9 [PMID: 25813608]
  3. Mater Sci Eng C Mater Biol Appl. 2015 Jun;51:356-61 [PMID: 25842145]
  4. J Microbiol Methods. 2003 Dec;55(3):599-605 [PMID: 14607403]
  5. Pol J Microbiol. 2012;61(2):95-104 [PMID: 23163208]
  6. Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76 [PMID: 25605354]
  7. J Appl Microbiol. 2005;98(5):1169-76 [PMID: 15836487]
  8. Microb Drug Resist. 2006 Fall;12(3):177-85 [PMID: 17002544]
  9. J Appl Microbiol. 2006 Oct;101(4):837-48 [PMID: 16968295]
  10. J Antimicrob Chemother. 2006 Mar;57(3):573-6 [PMID: 16431863]
  11. Semin Respir Crit Care Med. 2015 Feb;36(1):17-30 [PMID: 25643268]
  12. Langenbecks Arch Surg. 2015 Feb;400(2):153-65 [PMID: 25667169]
  13. Appl Environ Microbiol. 2006 Jun;72 (6):4245-9 [PMID: 16751538]
  14. J Agric Food Chem. 2011 May 25;59(10):5602-8 [PMID: 21469734]
  15. Can J Vet Res. 2014 Apr;78(2):110-6 [PMID: 24688172]
  16. Antimicrob Agents Chemother. 2012 Dec;56(12):6366-71 [PMID: 23070152]
  17. Appl Environ Microbiol. 2012 Feb;78(3):900-3 [PMID: 22138996]
  18. Appl Environ Microbiol. 2010 Jan;76(2):483-92 [PMID: 19933345]
  19. Antimicrob Agents Chemother. 2004 Jul;48(7):2778-81 [PMID: 15215149]
  20. FEMS Microbiol Lett. 2007 May;270(2):227-36 [PMID: 17326750]
  21. Peptides. 2013 Nov;49:53-8 [PMID: 23988790]
  22. J Bacteriol. 1998 Apr;180(8):1988-94 [PMID: 9555877]
  23. Med Sci (Paris). 2010 Nov;26(11):943-9 [PMID: 21106176]
  24. J Appl Microbiol. 2012 Oct;113(4):723-36 [PMID: 22583565]
  25. J Clin Diagn Res. 2015 Sep;9(9):DC01-4 [PMID: 26500902]
  26. Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72 [PMID: 7811020]
  27. Biosci Biotechnol Biochem. 2012;76(5):947-53 [PMID: 22738965]
  28. J Prev Med Hyg. 2014 Dec;55(4):137-44 [PMID: 26137787]
  29. Antimicrob Agents Chemother. 2013 Jun;57(6):2719-25 [PMID: 23571533]
  30. Ocul Immunol Inflamm. 2017 Feb;25(1):111-121 [PMID: 26679534]
  31. PLoS One. 2013 Jul 24;8(7):e68993 [PMID: 23894389]
  32. Clin Microbiol Rev. 2010 Jul;23(3):616-87 [PMID: 20610826]
  33. Antimicrob Agents Chemother. 2008 Mar;52(3):1094-100 [PMID: 18086839]
  34. Infez Med. 2015 Jun;23(2):99-104 [PMID: 26110289]
  35. Pathogens. 2014 May 06;3(2):404-16 [PMID: 25437807]
  36. J Antimicrob Chemother. 2016 Mar;71(3):576-86 [PMID: 26565015]
  37. Res Microbiol. 2012 Feb;163(2):101-8 [PMID: 22172555]
  38. Med Princ Pract. 2016;25(4):301-8 [PMID: 26684017]
  39. Front Microbiol. 2015 Apr 02;6:227 [PMID: 25883590]
  40. J Bacteriol. 1996 Jun;178(12):3585-93 [PMID: 8655558]
  41. Res Microbiol. 2011 Feb-Mar;162(2):99-107 [PMID: 20868743]
  42. APMIS. 2016 Mar;124(3):221-8 [PMID: 26709106]
  43. Curr Top Microbiol Immunol. 2008;322:207-28 [PMID: 18453278]
  44. Probiotics Antimicrob Proteins. 2010 Jun;2(2):98-103 [PMID: 26781118]
  45. Microbes Environ. 2011;26(3):254-60 [PMID: 21666390]
  46. J Bacteriol. 2000 Dec;182(23):6806-14 [PMID: 11073927]
  47. J Antimicrob Chemother. 2014 Jul;69(7):1877-87 [PMID: 24633205]
  48. Ups J Med Sci. 2014 May;119(2):149-53 [PMID: 24666223]

Word Cloud

Created with Highcharts 10.0.0bacteriocinsenterocinsDD28DD93MRSAchromatographyclinicalMRSA-S1strainMethicillin-resistantStaphylococcusaureusbecomeworrisomesuperbugworkaimedstudyingeffectstwoclassIIbanti-MRSAagentsThuspurifiedculturessupernatantsEnterococcusfaecalis2893usingsimplifiedpurificationprocedureconsistingcationexchangereversed-phasehigh-performanceliquidanti-StaphylococcalactivityshownvitroassessmentminimalinhibitoryconcentrationMICfollowedcheckerboardtime-killkineticsexperimentsdataunveiledclearsynergisticeffectcombinationerythromycinkanamycinBesidescombinationsimpededwellsetupbiofilmsstainlesssteelglacedevicesAnti-MRSAActivitiesEnterocinsEvidencesRoleInhibitionBiofilmFormationantibioticssynergism

Similar Articles

Cited By